论文信息 - Lung adenocarcinoma with concurrent exon 19 EGFR mutation and ALK rearrangement responding to erlotinib. - 字舞流文

Lung adenocarcinoma with concurrent exon 19 EGFR mutation and ALK rearrangement responding to erlotinib.

A. Nicholson | A. Wotherspoon | M. O'Brien | J. Swansbury | S. Popat | E. Lim | T. Min | M. Dainton | Alexandra Vieira de Araújo